skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Development of a New Subclavian Arterial Infusion Chemotherapy Method for Locally or Recurrent Advanced Breast Cancer Using an Implanted Catheter-Port System After Redistribution of Arterial Tumor Supply

Journal Article · · Cardiovascular and Interventional Radiology
; ; ; ; ;  [1];  [2]
  1. St. Marianna University School of Medicine, Department of Radiology (Japan)
  2. University of Rochester Medical Center, Department of Vascular/Interventional Radiology (United States)

Locally or recurrent advanced breast cancers can receive arterial blood supply from various arteries, such as the internal thoracic artery (ITA), the lateral thoracic artery, and the other small arterial branches originating from the subclavian artery. Failure to catheterize and subsequent formation of collateral arterial blood supply from various arteries are some of the reasons why the response to conventional selective transarterial infusion chemotherapy is limited and variable. To overcome this problem, we developed a new subclavian arterial infusion chemotherapy method using an implanted catheter-port system after redistribution of arterial tumor blood supply by embolizing the ITA. We named this technique ('redistributed subclavian arterial infusion chemotherapy' (RESAIC)). Using RESAIC, patients can be treated on an outpatient basis for extended periods of time. Eleven patients underwent RESAIC, and the complete remission and partial response rate in 10 evaluable patients was 90%: complete remission [CR] n = 4, partial remission n = 4, stable disease n = 1, and not evaluable n = 1. Three of four patients with CR had no distant metastasis, and modified radical mastectomy was performed 1 month after conclusion of RESAIC. The resected specimens showed no residual cancer cells, and pathologically confirmed complete remission was diagnosed in each of these cases. Although temporary grade-3 myelosuppression was seen in three patients who were previously treated by systemic chemotherapy, there was no other drug-induced toxicity or procedure-related complications. RESAIC produced a better response and showed no major complications compared with other studies despite the advanced stage of the cancers.

OSTI ID:
21429122
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 32, Issue 5; Other Information: DOI: 10.1007/s00270-009-9510-1; Copyright (c) 2009 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Article Copyright (c) 2009 Springer Science+Business Media, LLC; ISSN 0174-1551
Country of Publication:
United States
Language:
English

Similar Records

Complications Encountered with a Transfemorally Placed Port-Catheter System for Hepatic Artery Chemotherapy Infusion
Journal Article · Thu Mar 15 00:00:00 EST 2001 · Cardiovascular and Interventional Radiology · OSTI ID:21429122

Percutaneous implantation of a Port-Catheter System using the left subclavian artery
Journal Article · Sat Jan 15 00:00:00 EST 2000 · Cardiovascular and Interventional Radiology · OSTI ID:21429122

Percutaneous Implantation of a Port-Catheter System Using the Left Subclavian Artery
Journal Article · Sat Jan 15 00:00:00 EST 2000 · Cardiovascular and Interventional Radiology · OSTI ID:21429122